← Back to Search

Telehealth Hospice Visits for Breast Cancer

N/A

Waitlist Available

Led By Claire Smith, MD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient of any gender with unresectable locally advanced or metastatic breast cancer

Be older than 18 years old

Must not have

Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Unable to provide verbal consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 4 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study the experience of in-home hospice care for patients, caregivers, nurses, and doctors by using telehealth check-ins between patients, caregivers, and oncology teams.

Who is the study for?

The COMPASSION Study is for individuals with breast cancer who are currently receiving in-home hospice care. It's designed to understand the experience of patients, caregivers, and healthcare providers by using telehealth check-ins.

What is being tested?

This study tests the effectiveness of telehealth visits as a way to support people with breast cancer and their caregivers during in-home hospice care, involving regular virtual interactions with oncology teams.

What are the potential side effects?

Since this trial involves non-medical interventions like telehealth visits, there are no direct medical side effects associated. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have advanced breast cancer that cannot be removed by surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am 18 years old or older.

Select...

I cannot give verbal consent.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of Participant Intervention Completion

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Compassion CohortExperimental Treatment1 Intervention

25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone. * 4 weekly check-ins via Zoom or phone call with study team.

Group II: Usual Care CohortActive Control1 Intervention

25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone.

0 / 3Eligibility criteria met